Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Nuclear Medicine
Published in: Annals of Nuclear Medicine 4/2009

01-06-2009 | Original Article

Bioevaluation of 90Y-labeled particles in animal model of arthritis

Authors: Usha Pandey, Ketaki Bapat, Haladhar Dev Sarma, Prem Singh Dhami, P. W. Naik, Grace Samuel, Meera Venkatesh

Published in: Annals of Nuclear Medicine | Issue 4/2009

Login to get access

Abstract

Objective

The aim of the present study was to evaluate the behaviour of 90Y-labeled particles when injected into an arthritic knee joint of Wistar rats with severe inflammation induced using Complete Freund’s Adjuvant (CFA).

Methods

90Y-ferric hydroxide macroaggregates (90Y-FHMA), 90Y-hydroxyapatite (90Y-HA) and 90Y-phosphate particles (90YPO4) were prepared, subjected to quality control analyses and in vitro stability studies. Biodistribution studies were carried out by intra-articular injection into knee joints of Wistar rats induced with chronic inflammatory arthritis using CFA and by monitoring the radioactivity for retention and leakage.

Results

All the three preparations exhibited ~99% localization in knee joints even at 24 h p.i. with very small amounts observed in the liver and lungs, possibly due to leakage of the radiolabeled particles from the inflamed knee joint. Absence of any radioactivity in the femur indicated the in vivo stability of the particle preparations.

Conclusions

The biodistribution patterns were very similar in the normal and arthritic rats and were associated with negligible leakage (up to 24 h) from the knee joint indicating the potential of all the 90Y-radiolabeled preparations reported here, for use in radiation synoviorthesis.
Literature
1.
Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84:223–43.PubMedCrossRef
2.
Smolen JS, Steiner G. Rheumatoid arthritis is more than cytokines: autoimmunity and rheumatoid arthritis. Arthritis Rheum. 2001;44:2218–20.PubMedCrossRef
3.
Mödder G. Radiosynoviorthesis-involvement of nuclear medicine in rheumatology and orthopaedics. Germany: Warlich Druck und Verlagsges; 1995.
4.
Shin BC, Park KB, Jang BS, Lim SM, Shim CK. Preparation of 153Sm-chitosan complex for radiation synovectomy. Nucl Med Biol. 2001;28:719–25.PubMedCrossRef
5.
Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis and causes of death in rheumatoid arthritis. Arthritis Rheum. 1986;29:706–14.PubMedCrossRef
6.
Ranawat CS, Ecker ML, Straub LR. Synovectomy and debridement of the knee in rheumatoid arthritis. Arthritis Rheum. 1972;15:571–81.PubMedCrossRef
7.
Hosain F, Haddon MJ, Hosain H, Drost JK, Spencer RP. Radiopharmaceuticals for diagnosis and treatment of arthritis. Nucl Med Biol. 1990;17:151–5.
8.
Siegel ME, Siegal HJ, Luck JY. Radiosynovectomy’s clinical applications and cost effectiveness: a review. Semin Nucl Med. 1997;4:364–71.CrossRef
9.
Deutsch E, Brodack JW, Deutsch KF. Radiation synovectomy revisited. Eur J Nucl Med. 1993;20:1113–27.PubMedCrossRef
10.
Das BK, Modder G, Pradhan PK, Shukla AK. Concept of radiosynovectomy: a novel approach in the treatment of joint disorders. Ind J Nucl Med. 2004;19:1–5.
11.
Harbert JC. Radionuclide therapy in joint diseases. In: Harbert JC, Eckelman WC, Neumann RD, editors. Nuclear medicine diagnosis and therapy. New York: Thieme Medical Publishers; 1996. p. 1093–109.
12.
Johnson LS, Yanch JC. Absorbed dose profiles for radionuclides of frequent use in radiation synovectomy. Arthritis Rheum. 1991;34:1521–30.PubMed
13.
Noble J, Jones AG, Davis MA, Sledge CB, Kramer RI, Livni E. Leakage of radioactive particle systems from a synovial joint studied with a gamma camera: its applications to radiation synovectomy. J Bone Joint Surg. 1983;65A:381–9.
14.
Philippe L, Gegoat-Pottie P, Guingamp C, Bordji K, Terlain B, Netter P, et al. Relations between functional, inflammatory and degenerative parameters during adjuvant arthritis in rats. Am J Physiol Regul Integr Comp Physiol. 1997;273:R1550–6.
15.
Kasai M, Takemoto Y, Mizumara K. Induction of arthritis by complete Freund’s adjuvant in young male Wistar rats. Environ Med. 1998;42:103–4.
16.
Chinol M, Vallabhajosula S, Zuckerman JD, Goldsmith SJ. In vivo stability of ferric hydroxide macroaggregates (FHMA): is it a suitable carrier for radionuclides used in synovectomy? Nucl Med Biol. 1990;17:479–86.
17.
Pandey U, Mukherjee A, Chaudhary PR, Pillai MRA, Venkatesh M. Preparation and studies with particles labeled with 90Y for use in radiation synovectomy. Appl Radiat Isot. 2001;55:471–5.PubMedCrossRef
18.
Pandey U, Bapat K, Samuel G, Sarma HD, Chaudhari PR, Dhami PS, et al. Evaluation of 90Yttrium phosphate particles as a possible radiation synovectomy agent. Nucl Med Commun. 2005;26:459–63.PubMedCrossRef
19.
Dhami PS, Naik PW, Dudwadkar NL, Kannan R, Achuthan PV, Moorthy AV, et al. Studies on the development of a two stage supported liquid membrane system for the separation of carrier-free 90Y using KSM-17 and CMPO as carriers. Sep Sci Technol. 2007;42:1107–21.CrossRef
20.
Hayek E, Newesely H. Pentacalcium monohydroxy orthophosphate (hydroxyapatite). Inorg Synth. 1963;7:63–5.CrossRef
Metadata
Title
Bioevaluation of 90Y-labeled particles in animal model of arthritis
Authors
Usha Pandey
Ketaki Bapat
Haladhar Dev Sarma
Prem Singh Dhami
P. W. Naik
Grace Samuel
Meera Venkatesh
Publication date
01-06-2009
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 4/2009
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-009-0239-3

Other articles of this Issue 4/2009

Annals of Nuclear Medicine 4/2009 Go to the issue

Original Article

Significance of 18F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography

Case Report

Findings of hepatopulmonary syndrome on breath-hold perfusion SPECT-CT fusion images

Original Article

Measurement of cerebral blood flow by the autoradiographic method with N-isopropyl-4-[I-123] iodoamphetamine: comparison of radiopharmaceuticals marketed by different companies in Japan

Original Article

Prognostic value of myocardial perfusion and ventricular function in a Japanese multicenter cohort study (J-ACCESS): the first-year total events and hard events

Original Article

Differentiation of FDG-avid loco-regional recurrent and compromised benign lesions after surgery for breast cancer with dual-time point F-18-fluorodeoxy-glucose PET/CT scan

Invited Review Article

Cardiac hybrid imaging: state-of-the-art